medication for at least 24 hours. The initial problem was to reassure patients, who were obsessive people and who might believe that medicine must be taken three or four times daily, that to go without it for a short period would not produce a resurgence of symptoms. Although the evidence was limited, it seemed that patients on a drug holiday regimen over a three-year period had a lower incidence of tardive dyskinesia than those on continuous neuroleptic therapy.
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Not only should doctors strive for drug holidays, but once the high dose therapy had elevated the patient from a personal psychosis, his status and dosage requirements were changing. The physician should then strive for the lowest possible maintenance dose. Over this period there should be a progressive reduction in the amount of medication given. A drug has been defined as any substance which when injected into a cat produces a paper. Haloperidol has been injected into animals, as we have heard, and has produced 2200 papers. This morning we have had a wide range of information about the action of haloperidol, ranging from animal studies to pharmacodynamics and pharmacokinetics, and the clinical contribution which Dr Ayd has presented to us. We have heard that haloperidol in contrast to chlorpromazine has specific antagonistic effects to apomorphine; it specifically blocks dopamine receptors and increases the turnover of dopamine. It is also antagonistic to the action of amphetamines. These are specific effects when compared with chlorpromazine. However, its action in producing ptosis and its action on tryptamine are different from chlorpromazine. These two measures relate to sedative action and haloperidol, as we have heard from many speakers, has much less sedative action than chlorpromazine. Similarly, its action on the a-adrenergic receptors is much less than chlorpromazine and this fits with clinical observations that it has very little action or side-effects involving the cardiovascular system. Compared with chlorpromazine it is more potent weight for weight, it has a longer duration of action and it has a more rapid onset of action.
The next paper dealt with individual variations in the effect of haloperidol, particularly relating to its pharmacodynamic and pharmacokinetic actions and Dr Forsman described the three elements which were involved in this variation: the disease itself; the tissue responsiveness; and the concentration of the drug at the site of action. He showed how there was quite marked variation between individuals when on the same dose of drug. This was a variation of about tenfold. But we heard from others that this was much less than one finds with other neuroleptics and with tricyclic antidepressants.
Dr Forsman described how the sedative effects, whatever they are, come on within one hour, but there was a long delay of 12 to 16 hours before the extrapyramidal side-effects appeared. He described in detail the metabolic pathways and, in discussion, he referred to the fact that there was no evidence of any enzyme induction with haloperidol, and that the oral doses compared with parenteral administration had a longer half-life. He felt that this might be explained in terms of enterohepatic recirculation. He also pointed out the need for further research correlating serum levels with therapeutic effects. Dr Ayd very comprehensively described the clinical uses of haloperidol and described the appearance, disappearance and re-emergence of extrapyramidal side-effects according to the dosage. He discussed in detail dystonic reactions and parkinsonian side-effects and effective ways in which these can be managed. He also dealt in detail with the very troublesome tardive dyskinesia, a problem which worries us all, both in terms of effective ways of controlling it and also of trying to avoid its appearance in the first place.
I think the discussion has been excellent throughout the morning, and I would like to thank all the speakers for keeping to the time allotted with immaculate conscientiousness and also to thank the discussants for their contributions.
